Tim Friede's Venom Immunity Sparks New Antivenom Research
Groundbreaking research into snakebite treatment using unique antibodies from Tim Friede reveals potential for broad-spectrum antivenom.
Summary
After 18 years of self-immunization with venom, Tim Friede's antibodies have led researchers at Centivax to design a groundbreaking broad-spectrum antivenom. Studying Friede's blood, scientists identified two antibodies effective against venom from multiple snake species. Their experimental formula showed promise in mice, offering protection against 13 species and partial against others, but has yet to enter human trials. Despite its potential, experts caution more work is needed, particularly for snakes like vipers. Friede's unique journey, involving hundreds of snakebites, highlights a significant advancement in snakebite treatment amidst a global health crisis.
Sources (6)
- Tim Friede's self-experimentation demonstrates an extreme personal commitment to contributing to science, but raises concerns about safety and ethics, as such practices could inspire imitation without proper scientific backing.
CNN·19d· "…Glanville, who grew up in rural Guatemala, said he had long been aware of the health problems posed by snakebites and immediately recognized that Friede’s experience presented a unique opportunity."
IFL Science·20d· "…As astonishing and world-changing as it would be to have a single effective antivenom that could be kept everywhere refrigeration exists, the path to this point is possibly more amazing."
The Guardian·20d· "…The cocktail, which combines two protective antibodies from Friede’s blood and a small molecule venom inhibitor, opens a path towards a universal antivenom, according to research published in the journal Cell."
FAQ
History
- 19d